BACKGROUND In June 2010, the Communities Putting Prevention to Work program (Centers for Disease Control and Prevention) funded a New Jersey (NJ) Office on Nutrition and Fitness, Department of Health and Senior Services project to reduce obesity and increase exclusive breastfeeding by increased implementation of the Baby-Friendly Hospital Initiative in the state of NJ. At baseline, NJ had no Ba...

This article tried to explain that the phenomenon of Chinese Indonesians in eyes Native had received such diverse perceptions, it often seemed tendentious. However, recent years, view was disappeared due a change term designation stipulated state legislation by no longer using Chinese, but Indonesian people descent. The main problem this study how shifting cultural assimilation patterns an impa...

Despite scientific uncertainty regarding the relative safety of inhaling e-cigarette aerosol and flavorings, some consumers regard the U.S. Food and Drug Administration's "generally recognized as safe" (GRAS) designation as evidence of flavoring safety. In this study, we assessed how college students' perceptions of e-cigarette flavoring safety are related to understanding of the GRAS designati...

BACKGROUND We studied to what extent the level of scientific knowledge on exceptionally rare metabolic inherited diseases and their potential orphan medicinal products is associated with sponsors deciding to apply for an orphan designation at the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA). METHODS All metabolic diseases with a genetic cause and prevalence of ...

Colleagues disagree with statements in our discussion (Cronin et al. 2015) regarding subspecies taxonomy of wolves (Canis lupus) in southeast Alaska (Weckworth et al. 2015) and the southwest United States (Fredrickson et al. 2015). Following the presentation of results of single nucleotide polymorphism (SNP) variation in several populations of wolves in North America, we discussed other genetic...

BACKGROUND Orphan designated medicinal products benefit from regulatory and economic incentives for orphan drug development. Approximately 40% of orphan designations target rare neoplastic disorders, referring to rare cancers. In order to provide more insights in drugs for rare neoplastic disorders that are under development and to better understand the role of orphan designation in the develop...